We don't cover ADRX, and we'd rather say so than guess.

ADARx Pharmaceuticals, Inc. (ADRX) is a $1.6B-cap name with thin filing history and little wire coverage. There isn't enough source material to explain a move honestly — and an explanation we can't source is worse than none.

WHAT WE DO HAVE

LAST PRICE

14.20

−4.8%

SOURCES FOUND

5

not enough to source a cause

COVERAGE FLOOR

$2.0B

or a daily mover

TRY A COVERED NAME

TODAY'S MOVERS CALENDAR

DID YOU MEAN

HADRXHorizon Defined Risk Advisor−0.1%VADRXInvesco Equally-Weighted S&P 500 Fund Class R+0.2%

Small caps with no filings and no coverage produce bad explanations. Drawing the line publicly is the point — it's how you know every other answer here means something.